DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Nuclear Medicine Diagnostics Market (SPECT and PET) - Analysis and Forecasts (2015-2020)" report to their offering.
The Global Nuclear Medicine Market is expected to reach USD 17,600 million by the end of 2019 growing at a CAGR of around 12.29% from 2014 to 2019. Nuclear Medicine utilizes the radioisotope for application in diagnosis and treatment of diseases.
The Nuclear Medicine for diagnostic purposes have gained a huge popularity all round the world. There have been increased use of SPECT, PET, CT, MRI for diagnosis of cardiac diseases, Brain diseases, Cancer and many others. Nuclear medicine is being used for therapeutic purposes for treatment of Alzheimer's disease, coronary heart diseases, bone metastasis and many other cancers. Advancement in Diagnostic imaging is bringing in more use of Nuclear medicine. Nuclear Cardiology have gained a great popularity in North America. Nuclear Medicine for therapeutic purposes is being used for treatment of cancers, different medical conditions affecting thyroid gland, and scar - tissue removal.
The increasing incidence and prevalence of cancer and cardiac ailments, increasing applications of SPECT and PET with advancement of technology and growing awareness amongst physicians and public awareness for better healthcare are key factors driving the growth of Nuclear medicine market. However, Short half-life of Radiopharmaceuticals, high capital investment required for development, stringent regulatory guidelines are factors turning out to be restraints for this market.
The increasing imaging technologies, potential radioisotopes in pipeline, increasing neurological applications and cyclotron based production are becoming key opportunities for growth of Nuclear Medicine Market.
- Lantheus Medical Imaging
- IBA Group
- Triad Isotope
- Siemens Healthcare
- NTP Radioisotopes
- Bracco Pharma
- Cambridge Isotope Laboratories
- Cardinal Health
- GE Healthcare
Taiya Nippon Sanso Corporation
For more information visit http://www.researchandmarkets.com/research/trr2fw/global_nuclear